# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-023400
Filing Date
2025-11-14
Accepted
2025-11-14 16:00:58
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1101555
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 21244
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 20676
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 7086
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 6734
6 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 36681
7 | GRAPHIC | form10-q_002.jpg | GRAPHIC | 67769
8 | GRAPHIC | form10-q_003.jpg | GRAPHIC | 15061
9 | GRAPHIC | form10-q_004.jpg | GRAPHIC | 19218
10 | GRAPHIC | form10-q_005.jpg | GRAPHIC | 15158
11 | GRAPHIC | form10-q_006.jpg | GRAPHIC | 12348
| Complete submission text file | 0001493152-25-023400.txt |  | 6524570

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | gtbp-20250930.xsd | EX-101.SCH | 49391
13 | XBRL CALCULATION FILE | gtbp-20250930_cal.xml | EX-101.CAL | 38949
14 | XBRL DEFINITION FILE | gtbp-20250930_def.xml | EX-101.DEF | 233264
15 | XBRL LABEL FILE | gtbp-20250930_lab.xml | EX-101.LAB | 429578
16 | XBRL PRESENTATION FILE | gtbp-20250930_pre.xml | EX-101.PRE | 347063
71 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 880421

Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 251485498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)